Skip to main navigation Skip to search Skip to main content

Potential mortality benefit from secondary prophylaxis following CMV treatment completion may be due to confounding by transplant organ type

Research output: Contribution to journalLetterOtherpeer-review

Original languageEnglish
Article numbere13051
Number of pages2
JournalTransplant Infectious Disease
Volume21
Issue number2
DOIs
Publication statusPublished - Apr 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this